カテゴリー： QYResearch, 世界, 医療/バイオ

サプロプテリンの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書（QY21JNE4003）
◆英語タイトル：Global Sapropterin Market Size, Status and Forecast 2021-2027
◆商品コード：QY21JNE4003
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2021年6月
◆ページ数：88
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥444,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥666,900見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥889,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
本調査資料では、サプロプテリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、経口液剤用粉末）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・サプロプテリンの市場動向
・企業の競争状況、市場シェア
・サプロプテリンの種類別市場規模（錠剤、経口液剤用粉末）
・サプロプテリンの用途別市場規模（病院、ドラッグストア）
・サプロプテリンの北米市場規模2016-2027（アメリカ、カナダ）
・サプロプテリンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・サプロプテリンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・サプロプテリンの中南米市場規模2016-2027（メキシコ、ブラジル）
・サプロプテリンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（BioMarin Pharmaceutical、Par、Dr Reddy's Laboratories）
・結論
【レポートの概要】

Sapropterin are approved to reduce blood Phe levels in people with a certain type of Phenylketonuria (PKU).

Market Analysis and Insights: Global Sapropterin Market
The global Sapropterin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sapropterin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sapropterin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sapropterin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sapropterin market.

Global Sapropterin Scope and Market Size
Sapropterin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sapropterin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablets
Powder for Oral Solution

Segment by Application
Hospital
Drug store

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BioMarin Pharmaceutical
Par
Dr Reddy’s Laboratories

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sapropterin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Powder for Oral Solution
1.3 Market by Application
1.3.1 Global Sapropterin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Sapropterin Market Perspective (2016-2027)
2.2 Sapropterin Growth Trends by Regions
2.2.1 Sapropterin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sapropterin Historic Market Share by Regions (2016-2021)
2.2.3 Sapropterin Forecasted Market Size by Regions (2022-2027)
2.3 Sapropterin Industry Dynamic
2.3.1 Sapropterin Market Trends
2.3.2 Sapropterin Market Drivers
2.3.3 Sapropterin Market Challenges
2.3.4 Sapropterin Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Sapropterin Players by Revenue
3.1.1 Global Top Sapropterin Players by Revenue (2016-2021)
3.1.2 Global Sapropterin Revenue Market Share by Players (2016-2021)
3.2 Global Sapropterin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sapropterin Revenue
3.4 Global Sapropterin Market Concentration Ratio
3.4.1 Global Sapropterin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sapropterin Revenue in 2020
3.5 Sapropterin Key Players Head office and Area Served
3.6 Key Players Sapropterin Product Solution and Service
3.7 Date of Enter into Sapropterin Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Sapropterin Breakdown Data by Type
4.1 Global Sapropterin Historic Market Size by Type (2016-2021)
4.2 Global Sapropterin Forecasted Market Size by Type (2022-2027)

5 Sapropterin Breakdown Data by Application
5.1 Global Sapropterin Historic Market Size by Application (2016-2021)
5.2 Global Sapropterin Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Sapropterin Market Size (2016-2027)
6.2 North America Sapropterin Market Size by Type
6.2.1 North America Sapropterin Market Size by Type (2016-2021)
6.2.2 North America Sapropterin Market Size by Type (2022-2027)
6.2.3 North America Sapropterin Market Size by Type (2016-2027)
6.3 North America Sapropterin Market Size by Application
6.3.1 North America Sapropterin Market Size by Application (2016-2021)
6.3.2 North America Sapropterin Market Size by Application (2022-2027)
6.3.3 North America Sapropterin Market Size by Application (2016-2027)
6.4 North America Sapropterin Market Size by Country
6.4.1 North America Sapropterin Market Size by Country (2016-2021)
6.4.2 North America Sapropterin Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Sapropterin Market Size (2016-2027)
7.2 Europe Sapropterin Market Size by Type
7.2.1 Europe Sapropterin Market Size by Type (2016-2021)
7.2.2 Europe Sapropterin Market Size by Type (2022-2027)
7.2.3 Europe Sapropterin Market Size by Type (2016-2027)
7.3 Europe Sapropterin Market Size by Application
7.3.1 Europe Sapropterin Market Size by Application (2016-2021)
7.3.2 Europe Sapropterin Market Size by Application (2022-2027)
7.3.3 Europe Sapropterin Market Size by Application (2016-2027)
7.4 Europe Sapropterin Market Size by Country
7.4.1 Europe Sapropterin Market Size by Country (2016-2021)
7.4.2 Europe Sapropterin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Sapropterin Market Size (2016-2027)
8.2 Asia-Pacific Sapropterin Market Size by Type
8.2.1 Asia-Pacific Sapropterin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sapropterin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sapropterin Market Size by Type (2016-2027)
8.3 Asia-Pacific Sapropterin Market Size by Application
8.3.1 Asia-Pacific Sapropterin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sapropterin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sapropterin Market Size by Application (2016-2027)
8.4 Asia-Pacific Sapropterin Market Size by Region
8.4.1 Asia-Pacific Sapropterin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sapropterin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Sapropterin Market Size (2016-2027)
9.2 Latin America Sapropterin Market Size by Type
9.2.1 Latin America Sapropterin Market Size by Type (2016-2021)
9.2.2 Latin America Sapropterin Market Size by Type (2022-2027)
9.2.3 Latin America Sapropterin Market Size by Type (2016-2027)
9.3 Latin America Sapropterin Market Size by Application
9.3.1 Latin America Sapropterin Market Size by Application (2016-2021)
9.3.2 Latin America Sapropterin Market Size by Application (2022-2027)
9.3.3 Latin America Sapropterin Market Size by Application (2016-2027)
9.4 Latin America Sapropterin Market Size by Country
9.4.1 Latin America Sapropterin Market Size by Country (2016-2021)
9.4.2 Latin America Sapropterin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Sapropterin Market Size (2016-2027)
10.2 Middle East & Africa Sapropterin Market Size by Type
10.2.1 Middle East & Africa Sapropterin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sapropterin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sapropterin Market Size by Type (2016-2027)
10.3 Middle East & Africa Sapropterin Market Size by Application
10.3.1 Middle East & Africa Sapropterin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sapropterin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sapropterin Market Size by Application (2016-2027)
10.4 Middle East & Africa Sapropterin Market Size by Country
10.4.1 Middle East & Africa Sapropterin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sapropterin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BioMarin Pharmaceutical
11.1.1 BioMarin Pharmaceutical Company Details
11.1.2 BioMarin Pharmaceutical Business Overview
11.1.3 BioMarin Pharmaceutical Sapropterin Introduction
11.1.4 BioMarin Pharmaceutical Revenue in Sapropterin Business (2016-2021)
11.1.5 BioMarin Pharmaceutical Recent Development
11.2 Par
11.2.1 Par Company Details
11.2.2 Par Business Overview
11.2.3 Par Sapropterin Introduction
11.2.4 Par Revenue in Sapropterin Business (2016-2021)
11.2.5 Par Recent Development
11.3 Dr Reddy’s Laboratories
11.3.1 Dr Reddy’s Laboratories Company Details
11.3.2 Dr Reddy’s Laboratories Business Overview
11.3.3 Dr Reddy’s Laboratories Sapropterin Introduction
11.3.4 Dr Reddy’s Laboratories Revenue in Sapropterin Business (2016-2021)
11.3.5 Dr Reddy’s Laboratories Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Sapropterin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of Powder for Oral Solution
Table 4. Global Sapropterin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Sapropterin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Sapropterin Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Sapropterin Market Share by Regions (2016-2021)
Table 8. Global Sapropterin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Sapropterin Market Share by Regions (2022-2027)
Table 10. Sapropterin Market Trends
Table 11. Sapropterin Market Drivers
Table 12. Sapropterin Market Challenges
Table 13. Sapropterin Market Restraints
Table 14. Global Sapropterin Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Sapropterin Market Share by Players (2016-2021)
Table 16. Global Top Sapropterin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sapropterin as of 2020)
Table 17. Ranking of Global Top Sapropterin Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Sapropterin Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Sapropterin Product Solution and Service
Table 21. Date of Enter into Sapropterin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sapropterin Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Sapropterin Revenue Market Share by Type (2016-2021)
Table 25. Global Sapropterin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Sapropterin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Sapropterin Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Sapropterin Revenue Market Share by Application (2016-2021)
Table 29. Global Sapropterin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Sapropterin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Sapropterin Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Sapropterin Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Sapropterin Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Sapropterin Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Sapropterin Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Sapropterin Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Sapropterin Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Sapropterin Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Sapropterin Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Sapropterin Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Sapropterin Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Sapropterin Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Sapropterin Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Sapropterin Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Sapropterin Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Sapropterin Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Sapropterin Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Sapropterin Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Sapropterin Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Sapropterin Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Sapropterin Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Sapropterin Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Sapropterin Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Sapropterin Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Sapropterin Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Sapropterin Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Sapropterin Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Sapropterin Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Sapropterin Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Sapropterin Market Size by Country (2022-2027) & (US$ Million)
Table 61. BioMarin Pharmaceutical Company Details
Table 62. BioMarin Pharmaceutical Business Overview
Table 63. BioMarin Pharmaceutical Sapropterin Product
Table 64. BioMarin Pharmaceutical Revenue in Sapropterin Business (2016-2021) & (US$ Million)
Table 65. BioMarin Pharmaceutical Recent Development
Table 66. Par Company Details
Table 67. Par Business Overview
Table 68. Par Sapropterin Product
Table 69. Par Revenue in Sapropterin Business (2016-2021) & (US$ Million)
Table 70. Par Recent Development
Table 71. Dr Reddy's Laboratories Company Details
Table 72. Dr Reddy's Laboratories Business Overview
Table 73. Dr Reddy's Laboratories Sapropterin Product
Table 74. Dr Reddy's Laboratories Revenue in Sapropterin Business (2016-2021) & (US$ Million)
Table 75. Dr Reddy's Laboratories Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sapropterin Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. Powder for Oral Solution Features
Figure 4. Global Sapropterin Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Sapropterin Report Years Considered
Figure 8. Global Sapropterin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Sapropterin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Sapropterin Market Share by Regions: 2020 VS 2027
Figure 11. Global Sapropterin Market Share by Regions (2022-2027)
Figure 12. Global Sapropterin Market Share by Players in 2020
Figure 13. Global Top Sapropterin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sapropterin as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Sapropterin Revenue in 2020
Figure 15. Global Sapropterin Revenue Market Share by Type (2016-2021)
Figure 16. Global Sapropterin Revenue Market Share by Type (2022-2027)
Figure 17. North America Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Sapropterin Market Share by Type (2016-2027)
Figure 19. North America Sapropterin Market Share by Application (2016-2027)
Figure 20. North America Sapropterin Market Share by Country (2016-2027)
Figure 21. United States Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Sapropterin Market Share by Type (2016-2027)
Figure 25. Europe Sapropterin Market Share by Application (2016-2027)
Figure 26. Europe Sapropterin Market Share by Country (2016-2027)
Figure 27. Germany Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Sapropterin Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Sapropterin Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Sapropterin Market Share by Region (2016-2027)
Figure 37. China Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Sapropterin Market Share by Type (2016-2027)
Figure 45. Latin America Sapropterin Market Share by Application (2016-2027)
Figure 46. Latin America Sapropterin Market Share by Country (2016-2027)
Figure 47. Mexico Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Sapropterin Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Sapropterin Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Sapropterin Market Share by Country (2016-2027)
Figure 53. Turkey Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Sapropterin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. BioMarin Pharmaceutical Revenue Growth Rate in Sapropterin Business (2016-2021)
Figure 57. Par Revenue Growth Rate in Sapropterin Business (2016-2021)
Figure 58. Dr Reddy's Laboratories Revenue Growth Rate in Sapropterin Business (2016-2021)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed


【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ サプロプテリンの世界市場規模・現状・予測2021年-2027年(Global Sapropterin Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ペプチドマイクロアレイの世界市場規模・現状・予測2021年-2027年 Peptide microarrays is the powerful technology in the field of proteomics and clinical assays that trace the binding activities, histone-modifying enzymes and function of protein linkages on a large scale. Market Analysis and Insights: Global Peptide Microarray Market The global Peptide Microarray market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peptide Microarray market to help players in achieving a strong market...
  • ロミプロスティムの世界市場規模・現状・予測2021年-2027年 Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production. Market Analysis and Insights: Global Romiplostim Market The global Romiplostim market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Romiplostim market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall...
  • 重粒子線治療の世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global Heavy Ion Therapy Market The global Heavy Ion Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Heavy Ion Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Heavy Ion Therapy market in terms...
  • エトラビリンの世界市場規模・現状・予測2021年-2027年 Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine. Market Analysis and Insights: Global Etravirine Market The global Etravirine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available...
  • イクサベピロンの世界市場規模・現状・予測2021年-2027年 Ixabepilone (INN; also known as azaepothilone B, codenamed BMS-247550) is a pharmaceutical drug developed by Bristol-Myers Squibb as a chemotherapeutic medication for cancer. Market Analysis and Insights: Global Ixabepilone Market The global Ixabepilone market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ixabepilone market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall...
  • リンコマイシンの世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global Lincomycin Market The global Lincomycin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lincomycin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lincomycin market in terms of revenue. On the whole, the report proves...
  • 色汗症治療の世界市場規模・現状・予測2021年-2027年 Chromhidrosis is a rare condition characterized by the secretion of colored sweat. There are two types of glands such as apocrine and eccrine gland. Apocrine glands secrete a milky sweat that, once fragmented down by bacteria, is the main cause of body odor whereas Eccrine glands secrete an odorless, clear fluid that serves to regulate body temperature. In addition, Chromhidrosis can be caused by various agents such as coloring agents used as food additives and this is anticipated to increase the demand for Chromhidrosis Treatment. There are three types of Chromhidrosis which includes Apocrine chromhidrosis, True eccrine chromhidrosis, Pseudo-eccrine chromhidrosis....
  • ドリペネムの世界市場規模・現状・予測2021年-2027年 Doripenem is an ultra-broad-spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand name Finibax in 2005 and is being marketed outside Japan by Johnson & Johnson. It is particularly active against Pseudomonas aeruginosa. The usual form is doripenem monohydrate. Market Analysis and Insights: Global Doripenem Market The global Doripenem market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report...
  • インターロイキン12受容体の世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global Interleukin 12 Receptor Market The global Interleukin 12 Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Interleukin 12 Receptor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Interleukin 12 Receptor market in terms...
  • 二重特異性モノクローナル抗体の世界市場規模・現状・予測2021年-2027年 A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen. Market Analysis and Insights: Global Bispecific Monoclonal Antibodies Market The global Bispecific Monoclonal Antibodies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report...
  • ラノラジンの世界市場規模・現状・予測2021年-2027年 Ranolazine, sold under the trade name Ranexa by Gilead Sciences, is a drug to treat angina that was first approved in 2006. Market Analysis and Insights: Global Ranolazine Market The global Ranolazine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ranolazine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market...
  • COPD治療薬の世界市場規模・現状・予測2021年-2027年 Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity, and the fifth-leading cause of death in the world. Market Analysis and Insights: Global COPD Therapeutics Market The global COPD Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key...
  • シクレソニドの世界市場規模・現状・予測2021年-2027年 Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, and Zetonna for hay fever in the US and Canada. Market Analysis and Insights: Global Ciclesonide Market The global Ciclesonide market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ciclesonide market to help players in achieving a strong...
  • 3D動脈スピンラベル標識法(3D ASL)の世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global 3D Arterial Spin Labeling(3D ASL) Market The global 3D Arterial Spin Labeling(3D ASL) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global 3D Arterial Spin Labeling(3D ASL) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global...
  • 動物用インスリンの世界市場規模・現状・予測2021年-2027年 Animal insulin is derived from cows and pigs. Animal insulin was the first type of insulin to be administered to humans to control diabetes. Until the 1980s, animal insulin was the only treatment for insulin dependent diabetes. Currently, the use of animal insulin has been largely replaced by human insulin and human analogue insulin, however, animal insulin is still available on prescription. Market Analysis and Insights: Global Animal Insulin Market The global Animal Insulin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard...